BNP Paribas Arbitrage SA Has $19.61 Million Position in HCP, Inc. (HCP)
BNP Paribas Arbitrage SA reduced its position in shares of HCP, Inc. (NYSE:HCP) by 2.3% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 613,506 shares of the real estate investment trust’s stock after selling 14,522 shares during the period. BNP Paribas Arbitrage SA’s holdings in HCP were worth $19,608,000 as of its most recent filing with the SEC.
Other institutional investors have also recently bought and sold shares of the company. Bank of Montreal Can raised its stake in shares of HCP by 0.9% in the first quarter. Bank of Montreal Can now owns 372,934 shares of the real estate investment trust’s stock valued at $11,665,000 after buying an additional 3,258 shares during the last quarter. Fox Run Management L.L.C. bought a new stake in shares of HCP during the first quarter valued at approximately $497,000. DnB Asset Management AS raised its stake in shares of HCP by 18.6% in the first quarter. DnB Asset Management AS now owns 50,366 shares of the real estate investment trust’s stock valued at $1,575,000 after buying an additional 7,900 shares during the last quarter. Nisa Investment Advisors LLC raised its stake in shares of HCP by 31.5% in the first quarter. Nisa Investment Advisors LLC now owns 112,761 shares of the real estate investment trust’s stock valued at $3,527,000 after buying an additional 27,040 shares during the last quarter. Finally, Quantitative Systematic Strategies LLC bought a new stake in shares of HCP during the first quarter valued at approximately $859,000. Hedge funds and other institutional investors own 88.87% of the company’s stock.
HCP, Inc. (HCP) opened at 28.85 on Friday. The firm has a market cap of $13.53 billion, a P/E ratio of 19.67 and a beta of 0.37. HCP, Inc. has a 52 week low of $27.61 and a 52 week high of $40.43. The company has a 50-day moving average of $30.83 and a 200 day moving average of $31.23.
HCP (NYSE:HCP) last released its quarterly earnings results on Tuesday, August 1st. The real estate investment trust reported $0.48 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.47 by $0.01. HCP had a return on equity of 9.96% and a net margin of 32.16%. The business had revenue of $458.90 million during the quarter, compared to analyst estimates of $456.29 million. During the same quarter last year, the company posted $0.71 EPS. HCP’s revenue for the quarter was down 14.8% on a year-over-year basis. On average, equities analysts predict that HCP, Inc. will post $1.36 earnings per share for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, August 22nd. Investors of record on Monday, August 7th will be paid a $0.37 dividend. This represents a $1.48 annualized dividend and a yield of 5.13%. The ex-dividend date of this dividend is Thursday, August 3rd. HCP’s dividend payout ratio is currently 102.07%.
TRADEMARK VIOLATION WARNING: “BNP Paribas Arbitrage SA Has $19.61 Million Position in HCP, Inc. (HCP)” was first reported by Daily Political and is the property of of Daily Political. If you are viewing this report on another publication, it was illegally copied and republished in violation of US and international copyright & trademark law. The correct version of this report can be accessed at https://www.dailypolitical.com/2017/08/19/bnp-paribas-arbitrage-sa-has-19-61-million-position-in-hcp-inc-hcp-2.html.
HCP has been the topic of several research analyst reports. BidaskClub lowered shares of HCP from a “buy” rating to a “hold” rating in a research report on Thursday, June 29th. Zacks Investment Research lowered shares of HCP from a “hold” rating to a “sell” rating in a research report on Tuesday, July 18th. Stifel Nicolaus restated a “hold” rating and set a $31.00 target price on shares of HCP in a research report on Friday, July 14th. Goldman Sachs Group, Inc. (The) lowered shares of HCP from a “buy” rating to a “neutral” rating and decreased their target price for the stock from $35.00 to $32.00 in a research report on Monday, July 24th. Finally, Royal Bank Of Canada restated a “hold” rating and set a $31.00 target price on shares of HCP in a research report on Wednesday, July 5th. Three equities research analysts have rated the stock with a sell rating, fifteen have assigned a hold rating and three have given a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and an average target price of $33.42.
In related news, insider Thomas Klaritch sold 2,651 shares of the stock in a transaction dated Tuesday, June 13th. The stock was sold at an average price of $31.53, for a total value of $83,586.03. Following the completion of the sale, the insider now directly owns 176,830 shares of the company’s stock, valued at approximately $5,575,449.90. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 0.22% of the stock is currently owned by corporate insiders.
HCP Company Profile
HCP, Inc is a self-administered real estate investment trust. The Company invests in real estate serving the healthcare industry in the United States. The Company’s segments include senior housing triple-net (SH NNN), senior housing operating portfolio (SHOP), life science and medical office. Its senior housing facilities include independent living facilities, assisted living facilities, memory care facilities, care homes, and continuing care retirement communities.
Want to see what other hedge funds are holding HCP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCP, Inc. (NYSE:HCP).
Receive News & Ratings for HCP Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP Inc. and related companies with MarketBeat.com's FREE daily email newsletter.